AlternativeMed
Relationship Graph Explorer

Follow the connections

Every herb, ingredient, formula, gene target, and disease — connected through real research. Search, pick a subject, and navigate the graph in any direction.

Plus 6,743 TCM formulas connecting herbs together
🏥 Disease / Health Topic

Recurrent Head And Neck Squamous Cell Carcinoma

3
Clinical Trials
0
Meta-Analyses
0
PubMed References
📋 Sample Trials
NCT00494182
Sorafenib in Combination With Carboplatin and Paclitaxel in Treating Participants With Metastatic or Recurrent Head and Neck Squamous Cell Cancer
Active_Not_Recruiting · Phase 2
NCT04282109
Study to Assess the Efficacy and Safety of Nivolumab in Combination with Paclitaxel in Subjects with Head and Neck Cancer Unable for Cisplatin-based Chemotherapy (NIVOTAX)
Completed · Phase 2
NCT04862650
Cemiplimab, Low-Dose Paclitaxel and Carboplatin for the Treatment of Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck
Suspended · Phase 2
📊 Sample Meta-Analyses
None linked yet.
📚 Sample References
None linked yet.
🏥 All Disease / Health Topic data fields for Recurrent Head And Neck Squamous Cell Carcinoma
🏥 Names
Disease Name
Recurrent Head And Neck Squamous Cell Carcinoma
Topic Type
disease
🧬 Ontology Classifications
DisGeNET Type
disease
UMLS Type
Neoplastic Process
MeSH Class
Neoplasms
🔗 External References
DisGeNET
C4524839
🔍 Raw view — every non-empty column on this row (21 fields)
name
Recurrent Head And Neck Squamous Cell Carcinoma
topic type
disease
disgenet disease type
disease
umls disease type
Neoplastic Process
mesh disease class
Neoplasms
umls disease type id
T191
mesh disease class id
C04
herb disease id
HBDIS026912
disgenet id
C4524839

⚗️ Related Ingredients

1 · compounds in this herb

📋 Clinical Trials

3 · subject of clinical study
NCT00494182 Sorafenib in Combination With Carboplatin and Paclitaxel in Treating Participant
→ Metastatic Head and Neck Squamous Cell Carcinoma|M
NCT04282109 Study to Assess the Efficacy and Safety of Nivolumab in Combination with Paclita
→ Recurrent Head and Neck Squamous Cell Carcinoma|He
NCT04862650 Cemiplimab, Low-Dose Paclitaxel and Carboplatin for the Treatment of Recurrent/M
→ Clinical Stage IV HPV-Mediated (p16-Positive) Orop
How relationships are computed
  • Clinical Trials / Meta-Analyses / References: direct foreign-key link via subject_entity_id (Phase 2d wireup)
  • Formula ↔ Herbs: text bridge via formulas.herbs_in_pinyin matching herbs.pinyin_name
  • Herb ↔ Ingredient: ACTIVE — direct link via herb_ingredients
  • Ingredient ↔ Target: ACTIVE — direct link via ingredient_targets
  • Target ↔ Disease: ACTIVE — direct link via target_health_topics
  • Herb → Target → Disease (full chemical spine): ACTIVE — joins all three link tables